Cercar

01/03/2022 Focal Point The crucial history of Down syndrome
Zaman, S, Fortea, J. Focal Point The crucial history of Down syndrome. LANCET NEUROLOGY. 2022; 21(3)DOI:10.1016/S1474-4422(22)00047-3. PMID:35182507. IF:48.000(Q1/1D).
01/01/2022 Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease
Villarejo-Galende, A, Garcia-Arcelay, E, Pinol-Ripoll, G, del Olmo-Rodriguez, A, Vinuela, F, Boada, M, Franco-Macias, E, de la Pena, AI, Riverol, M, Puig-Pijoan, A, Abizanda-Soler, P, Arroyo, R, Baquero-Toledo, M, Feria-Vilar, I, Balasa, M, Berbel, A, Rodriguez-Rodriguez, E, Vieira-Camposs, A, Garcia-Ribas, G, Rodrigo-Herrero, S, Terrancle, A, Prefasi, D, Lleo, A, Maurino, J. Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE. 2022; 90(2)DOI:10.3233/JAD-220696. PMID:36155523. IF:4.000(Q2/4D).
01/01/2022 Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders
Gómez de San José N., Goossens J., Al Shweiki M.R., Halbgebauer S., Oeckl P., Steinacker P., Danzer K.M., Graf H., Schönfeldt-Lecuona C., Belbin O., Lleó A., Vanmechelen E., Otto M.. Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders. JOURNAL OF PSYCHIATRIC RESEARCH. 2022; 156DOI:10.1016/j.jpsychires.2022.10.010. PMID:36323141. IF:4.800(Q2/4D).
01/01/2022 CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels
del Campo M., Peeters C.F.W., Johnson E.C.B., Vermunt L., Hok-A-Hin Y.S., van Nee M., Chen-Plotkin A., Irwin D.J., Hu W.T., Lah J.J., Seyfried N.T., Dammer E.B., Herradon G., Meeter L.H., van Swieten J., Alcolea D., Lleó A., Levey A.I., Lemstra A.W., Pijnenburg Y.A.L., Visser P.J., Tijms B.M., van der Flier W.M., Teunissen C.E.. CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. Nature Aging. 2022; 2(11)DOI:10.1038/s43587-022-00300-1. PMID:37118088. IF:(Q/D).
01/01/2022 Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
Valle-Tamayo N., Pérez-González R., Chiva-Blanch G., Belbin O., Serrano-Requena S., Sirisi S., González A.C., Giró O., Sánchez-Aced É., Dols-Icardo O., Alcolea D., Carmona-Iragui M., Jimenez A., Lleó A., Fortea J., Iulita M.F.. Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma. Jove-Journal of Visualized Experiments. 2022; 2022(186)DOI:10.3791/64107. PMID:35993755. IF:1.200(Q3/8D).
01/01/2022 Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk
Ali M., Sung Y.J., Wang F., Fernández M.V., Morris J.C., Fagan A.M., Blennow K., Zetterberg H., Heslegrave A., Johansson P.M., Svensson J., Nellgård B., Lleó A., Alcolea D., Clarimon J., Rami L., Molinuevo J.L., Suárez-Calvet M., Morenas-Rodríguez E., Kleinberger G., Haass C., Ewers M., Levin J., Farlow M.R., Perrin R.J., Cruchaga C.. Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk. PLoS One. 2022; 17DOI:10.1371/journal.pone.0267298. PMID:35617280. IF:3.700(Q2/4D).
01/01/2022 Smoking is associated with age at disease onset in Parkinson's disease
Rosas I., Morís G., Coto E., Blázquez-Estrada M., Suárez E., García-Fernández C., Martínez C., Herrera I.D., Pérez-Oliveira S., Álvarez V., Menéndez-González M., Adarmes-Gómez A.D., Aguilar M., Alvarez I., Barrero F.J., Bergareche Yarza J.A., Bonilla-Toribio M., Botía J.A., Boungiorno M.T., Buiza-Rueda D., Cámara A., Carrillo F., Cerdan D., Clarimón J., Compta Y., Diez-Fairen M., Dols-Icardo O., de Fabregues O., Cartagena P.S., Duarte J., Duran R., Escamilla-Sevilla F., Ezquerra M., Feliz C., Fernández-Santiago R., Fernández M., García-Ruiz P., Gómez-Garre P., Gomez Heredia M.J., Gonzalez-Aramburu I., Gorostidi A., Hoenicka J., Infante J., Jesús S., Jimenez-Escrig A., Kulisevsky J., Labrador-Espinosa M.A., Lopez-Sendon J.L., López de Munain A., Macias-Garcia D., Martínez-Torres I., Marín J., Marti M.J., Martínez-Castrillo J.C., Álvarez-Santullano M.M., Mínguez-Castellanos A., Mir P., Rezola E.M., Muñoz E., Pagonabarraga J., Pastor P., Errazquin F.P., Periñán M.T., Ruiz-Martínez J., Ruz C., Rodriguez A.S., Sierra M., Tabernero C., Tartari J.P., Tolosa E., Valldeoriola F., Vela L., Vives F., Pascual-Sedano B., Hernández-Vara J., Rolán D.V., Bandrés-Ciga S.. Smoking is associated with age at disease onset in Parkinson's disease. PARKINSONISM & RELATED DISORDERS. 2022; 97DOI:10.1016/j.parkreldis.2022.03.005. PMID:35364453. IF:4.100(Q2/3D).
01/12/2025 Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO
Puerta, R, de Rojas, I, García-González, P, Olivé, C, Sotolongo-Grau, O, García-Sánchez, A, García-Gutiérrez, F, Montrreal, L, Tartari, JP, Sanabria, A, Pytel, V, Lage, C, Quintela, I, Aguilera, N, Rodriguez-Rodriguez, E, Alarcón-Martín, E, Orellana, A, Pastor, P, Pérez-Tur, J, Piñol-Ripoll, G, de Munain, AL, García-Alberca, JM, Royo, JL, Bullido, MJ, Alvarez, V, Real, LM, Anchuelo, AC, Gómez-Garre, D, Larrad, MTM, Franco-Macías, E, Mir, P, Medina, M, Sánchez-Valle, R, Dols-Icardo, O, Sáez, ME, Carracedo, A, Tárraga, L, Alegret, M, Valero, S, Marquié, M, Boada, M, Juan, PS, Cavazos, JE, Cabrera-Socorro, A, Cano, A, Ruiz, A, Alzheimers Dis Neuroimaging Initiative. Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO. FUNCTIONAL & INTEGRATIVE GENOMICS. 2025; 25(1)DOI:10.1007/s10142-025-01581-6. PMID:40133566. IF:3.100(Q2/4D).